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Excessive energy intake greatly contributes to the development of nonalcoholic fatty liver 
disease (NAFLD) in modern society. To better understand the comprehensive mechanisms of 
NAFLD development, we investigated the metabolic alterations of rats with NAFLD induced by 
high-fat diet (HFD). Male Wistar rats were fed a HFD or standard chow for control. After 16 
weeks, rat serum was collected for biochemical measurement. The rats' livers were resected and 
subjected to histology inspection and gene expression analysis with complementary DNA 
microarray and metabolic analysis with gas chromatography–mass spectroscopy. In HFD rats, 
the serum cholesterol, triglycerides, glucose, and insulin contents were increased; and the total 
cholesterol and triglycerides in the livers were also significantly increased. Complementary DNA 
microarray analysis revealed that 130 genes were regulated by HFD. Together with real-time 
reverse transcriptase polymerase chain reaction, lipid metabolism regulatory members like sterol 
regulatory element binding factor 1 and stearoyl–coenzyme A desaturase 1 had up-regulation, 
whereas others like peroxisome proliferator–activated receptor, carnitine palmitoyltransferase 1, 
and 3-hydroxy-3-methylglutaryl–coenzyme A reductase had repressed expression, in HFD rat 
livers. Metabolomic analysis showed that tetradecanoic acid, hexadecanoic acid, and oleic acid 
had elevation and arachidonic acid and eicosapentaenoic acid had decreased content in HFD rat 
livers. Amino acids including glycine, alanine, aspartic acid, glutamic acid, and proline contents 
were decreased. The integrative results from transcriptomic and metabolomic studies revealed 
that, in HFD rat livers, fatty acid utilization through β-oxidation was inhibited and lipogenesis 
was enhanced. These observations facilitated our understanding of the pathways involved in the 




Excessive energy intake is an important contributor to the increase in nonalcoholic fatty liver 
disease (NAFLD) in modern society. Despite its prevalence, the underlying mechanisms of 
NAFLD are not fully understood. In addition to lipid accumulation in the liver caused by an 
excess intake of dietary fat, some lipid metabolism regulation genes associated with the 
development of NAFLD have been identified, such as genes encoding acyl–coenzyme A 
synthase, peroxisome proliferator–activated receptor γ, and SIRT1 protein [1-3]. These 
investigations have elucidated the path to the molecular mechanisms of NAFLD. However, this 
“gene-by-gene” strategy has constrained the research regarding the complex pathogenesis of 
NAFLD. Recent advances in high throughput “omic” technologies, including transcriptomics, 
proteomics, and metabolomics, have facilitated the assessment of multiple genes, proteins, and 
metabolites simultaneously, which appears to be essential for understanding the biological 
mechanisms of complex diseases. Previous studies have shown the pleiotropic effects of a high-
fat diet (HFD) producing global changes in gene expression profiles [4,5]. From a nutrigenomics 
perspective, nutrients are dietary signals that can be detected by the cellular sensor systems to 
influence gene and protein expression and, subsequently, metabolite production [6]. Thus, we 
propose that using the strategy of integrated omics technologies to document the global changes 
resulting from HFD feeding could provide comprehensive information to further the 
understanding of NAFLD pathogenesis. 
 
Recently, we studied the different responses to long-term HFD feeding in a group of Wistar rats, 
that is, obesity-prone and obesity-resistant rats, with a transcriptomic and metabolomic approach. 
Our results indicated that various physiologic changes happened in obesity-prone rats, including 
increased activity of the sympathetic nervous system, Krebs cycle, and an increased production 
of ketone bodies as compared with the obesity-resistant rats, despite both groups of rats being fed 
an identical diet [7]. Accordingly, in the present study, we intend to investigate changes related 
to lipid metabolism in hepatic tissue induced by HFD feeding with combined transcriptomic and 
metabolomic approaches. The variations in gene expression and liver metabolites will provide 
information that may contribute to a better comprehension of the regulation pathways of 
molecular pathogenesis of NAFLD and become a basis for therapy and new drug development. 
 
MATERIALS AND METHODS 
Animal care and sample collection 
The animal experiments were carried out under the Guidelines for Animal Experimentation of 
Shanghai University of Traditional Chinese Medicine (Shanghai, China), and the protocol was 
approved by the Animal Ethics Committee. Thirty 8-week-old male Wistar rats (210 ± 10 g) and 
animal food were commercially obtained from Shanghai Laboratory Animal. (SLAC, Shanghai, 
China). All animals were kept in a barrier system with regulated temperature (23°C-24°C) and 
humidity (60% ± 10%) and on a 12/12-hour light-dark cycle with lights on at 08:00 am. The rats 
were fed with certified standard chow (SC) and tap water ad libitum for 1-week acclimation. 
Standard chow contains 22.10% crude protein, 50% carbohydrate, and 5.28% crude fat, whereas 
HFD was composed of 10% lard, 5% egg yolk powder, 2% cholesterol, and 83% SC 
(Supplementary material Table S1). Twenty rats were randomly selected and fed with HFD for 
16 weeks, whereas the remaining 10 rats were fed SC over the experimental period. The body 
weight of each animal was measured weekly. At the end of the experiment, the animals were 
fasted overnight and then killed by anesthesia with sodium pentobarbital (100 mg/kg). Heparin 
anticoagulated plasma samples were collected, centrifuged (3000 rpm for 10 minute, 4 °C), and 
stored at −80°C. The livers were immediately weighed and frozen in liquid nitrogen and stored at 
−80°C for subsequent analysis. Formalin-fixed and paraffin-embedded livers were routinely 
processed for hematoxylin and eosin (H&E) staining. 
Biochemical measurements 
After overnight fasting, the lipid profile in rat serum, including triglycerides, total cholesterol, 
low-density lipoprotein cholesterol (LDL-c), and high-density lipoprotein cholesterol (HDL-c), 
was subjected to biochemical testing by routine procedures using a clinical biochemical analyzer 
(Roche Diagnostics, Mannheim, Germany) in Dongfang Hospital, Shanghai. At 15 weeks, rat 
serum glucose levels were measured with a handheld glucometer (Johnson & Johnson, Milpitas, 
CA) from whole blood drawn at the tail-tip capillary region; and insulin concentrations were 
measured at termination using a rat insulin radioimmunoassay kit (Dongya, Beijing, China). The 
analyzing process was conducted with strict adherence to the kits' instructions. The liver was 
homogenized in isopropanol at a concentration of 20 mg/mL and kept at 4°C for 2 hours. 
Afterward, the sample was centrifuged at 5000g for 15 minutes; and the suspension was 
collected for subsequent determination of cholesterol and triglycerides content in the liver by 




The rat complementary DNA microarray (Shanghai Biochip, Shanghai, China) covering 11 060 
genes and expressed sequence tags was used [8]. Total RNA was prepared from each rat's liver 
using Trizol reagent (Invitrogen, Carlsbad, CA), further purified with RNeasy Kit (Qiagen, 
Hilden, Germany), and checked with 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA). 
Two micrograms of total RNA was applied to amplify using Low RNA Input Linear 
Amplification Kit (Agilent Technologies). Equal amounts of the RNA from SC rats were pooled 
to serve as a reference sample and labeled with cyanine 5 (Cy5; GE Healthcare, Piscataway, NJ), 
whereas the RNA from 8 HFD rats was labeled with cyanine 3 (Cy3, GE Healthcare) 
individually. The equivalent Cy5- and Cy3-labeled probes were mixed and hybridized at 42°C 
for 16 hours, and washed using standard protocol. The microarray slides were scanned with 
Agilent G2565BA Scanner, and the image data were extracted using ImaGene 4.2 (Biodiscovery, 
Santa Monica, CA). 
 
Real-time reverse transcriptase polymerase chain reaction 
Reverse transcription was performed with total RNA, oligo (dT) primers, and Superscript II 
reverse transcriptase (Invitrogen). Real-time reverse transcriptase polymerase chain reaction 
(RT-PCR) based on SYBR Green II (Toyobo, Tokyo, Japan) was used to verify the results of 
microarray with the ABI Prism 7000 Sequence Detection System (Applied Biosystems, Foster 
City, CA). RNA samples from 3 rats in both the HFD and SC groups were tested. Gene 
expression was normalized to the expression of Gapdh as internal control; and subsequently, the 
data were analyzed using the comparative threshold cycle method. The PCR primer sequences 
are listed in Supplementary material Table S2. 
 
Metabolic profiling of liver tissue extracts 
Gas chromatography–mass spectroscopy (GC/MS)–based metabolic profiling was performed on 
the liver tissue extracts with established methods [9]. Liver tissue extracts were derivatized with 
ethylchloroformate (ECF) before instrumental analysis. Briefly, 600-μL aqueous extraction of 
liver tissue was added with 100 μL of l-2-chlorophenylalanine (0.10 mg/mL, internal standard 
for batch quality control), 400 μL of alcoholic extraction of liver tissue, and 100 μL of pyridine; 
derivatized with 50 μL of ECF at room temperature; and then ultrasonicated at 100 kHz for 60 
seconds. The derivatives were extracted with 300 μL of chloroform, and the pH was adjusted 
with 100 μL of NaOH (7 mol/L). The derivatization process was repeated by adding an 
additional 50 μL of ECF. The resultant mixtures were centrifuged at 3000 rpm for 3 minutes. 
Afterward, the aqueous layer was aspirated, whereas the chloroform layer containing derivatives 
was dehydrated with anhydrous sodium sulfate for subsequent instrumental analysis. 
 
Data analysis 
The microarray data were processed as before [10]. After normalization of the Cy3 and Cy5 
signals between and within chips with LOWESS progression, the Cy3/Cy5 signal ratios were log 
[2] transformed. Afterward, we applied the Significance Analysis of Microarray version 2.2.1 
protocol [11] to pick out the statistically significant gene expression regulations and took the 1-
class analysis at false discovery rate = 0.01, plus an average cutoff of 1.5-fold changes. All gene 
expression information in the experiment had been submitted to the Gene Expression Omnibus 
database with the registration no. GSE11492. The spectral processing and multivariate statistics 
for GC/MS-based metabolic profiling were performed with Matlab (The MathWorks, Inc, 




Phenotypic and biochemical parameters 
After 16 weeks, the HFD rats developed significantly higher body and liver weight in 
comparison with SC rats, although they consumed the same amount of food. The total 
cholesterol and triglyceride liver contents were increased by 25.7-fold (2.1 vs 54.1 mg/g liver, P 
< .01) and 8.5-fold (12.4 vs 105.5 mg/g liver, P < .01), respectively. Accordingly, histologic 
staining of liver tissue with H&E staining showed obvious fat droplet accumulation in livers of 
HFD-feeding rat (Fig. 1). The total cholesterol, LDL-c, triglycerides, glucose, and insulin were 
increased in the HFD-fed group, whereas the HDL-c was decreased (Table 1). 
 
 
Figure 1: Histologic detection of the rat livers. 
 







Table 1: Phenotypic and biochemical parameters 
Items SC rats (n = 10) HFD rats (n = 20) 
Daily food intake (g) 22 ± 2 23 ± 3 
Body weight (g)   
Initial 246 ± 7.8 253.1 ± 11 
Final 440.8 ± 15.6 481.7 ± 39.0* 
Liver   
Liver weight (g/100g body weight) 2.34 ± 0.15 3.38 ± 0.17† 
Triglycerides (mg/g liver) 12.4 ± 3.1 105.5 ± 22.0† 
Total cholesterol (mg/g liver) 2.1 ± 0.33 54.1 ± 8.7† 
Serum   
Total cholesterol (mmol/L) 1.61 ± 0.41 1.95 ± 0.19† 
HDL-c (mmol/L) 1.39 ± 0.30 1.11 ± 0.27* 
LDL-c (mmol/L) 0.18 ± 0.10 0.64 ± 0.16† 
Triglycerides (mmol/L) 0.84 ± 0.30 1.26 ± 0.36† 
Glucose (mmol/L) 5.14 ± 0.34 5.5 ± 0.26† 
Insulin (μU/mL) 48.45 ± 6.80 57.60 ± 7.25* 
Data are presented as means ± SD. Comparison was made between HFD rats and SC rats by 2-tailed Student t test. 
*P < .05. †P < .01. 
 
Transcriptomic profiles of rat liver 
Using SAM software analysis, 130 genes were selected to have more than 1.5-fold regulation. 
Among the regulated genes, the highest proportions were those related to lipid metabolism 
(Table 2 and Supplementary material Table S3). As a consequence of HFD feeding, liver lipid 
metabolism involving genes were mainly regulated. Cholesterol biosynthesis participating 
members, for example, 3-hydroxy-3-methylglutaryl–coenzyme A synthase 1, sterol-c4-methyl 
oxidase-like, isopentenyl-diphosphate δ isomerase, and emopamil binding protein, had decreased 
expression. The down-regulation also happened in steroid metabolism genes, including 
cytochrome P450, family 17, subfamily A, polypeptide 1; cytochrome P450, family 8, subfamily 
B, polypeptide 1; and hydroxysteroid (17-β) dehydrogenase 2, and the genes encoding fatty acid 
metabolism enzymes, such as fatty acid desaturase 1 (Fads1), enoyl coenzyme A hydratase 1 
(Ech1), and dodecenoyl–coenzyme A δ isomerase (Dci). Significantly, sterol regulatory element 
binding factor 1 (Srebf1) had increased expression, whereas expression of insulin-induced gene 1 
(Insig1) was repressed. 
 
Although no significant alterations of liver function parameters were detected in HFD rat (data 
not shown), inflammatory and stress response member genes were also detected. The acute 
inflammation cytokine chemokine (c-x-c motif) ligand 1 (Cxcl1) and complement regulator 
complement component factor h (Cfh) had up-regulation; the macrophage homeostasis cytokine 
chemokine (c-x-c motif) ligand 14 was repressed. In addition, stress response–associated 
encoding genes like RB2-associated binding protein 1, growth arrest and DNA-damage–
inducible 45 γ, and cold inducible RNA binding protein showed increased expression, whereas 
heat shock protein 1 was decreased. 
 
In addition to the results obtained with complementary DNA microarray, we conducted real-time 
RT-PCR for 12 lipid metabolism–associated genes and 6 antioxidant enzyme genes. The results 
showed a high consistency with the microarray data. Peroxisome proliferator–activated receptor 
(Ppara), carnitine palmitoyltransferase 1 (Cpt1), and 3-hydroxy-3-methylglutaryl–coenzyme A 
reductase had repression; and the lipogenesis transcription factor Srebf1 and stearoyl–coenzyme 
A desaturase 1 (Scd1) had significant up-regulation (Fig. 2). No significant regulations at gene 
expression level were found for the detected antioxidant enzymes (Supplementary material 
Figure S1). 
Table 2: Differentially expressed genes between HFD and SC rats 
Gene Description Fold change (HFD/SC) 
Lipid metabolism 
 Insig1 Insulin-induced gene 1 0.406 
 Sc4mol Sterol-c4-methyl oxidase-like 0.490 
 Idi1 Isopentenyl-diphosphate δ isomerase 0.640 
 Cyp17a1 Cytochrome p450, family 17, subfamily a, polypeptide 1 0.600 
 Fads1 Fatty acid desaturase 1 0.631 
 Ech1 Enoyl coenzyme a hydratase 1, peroxisomal 0.597 
 Mtmr4 Myotubularin-related protein 4 1.523 
 LOC246266 Lysophospholipase 0.395 
 Cyp8b1 Cytochrome p450, family 8, subfamily b, polypeptide 1 0.580 
 Srebf1 Sterol regulatory element binding factor 1 2.140 
 Ebp Phenylalkylamine Ca2+ antagonist (emopamil) binding protein 0.625 
 Nr1i2 Nuclear receptor subfamily 1, group i, member 2 0.662 
 Dci Dodecenoyl–coenzyme A δ isomerase 0.409 
 Hmgcs1 3-Hydroxy-3-methylglutaryl–coenzyme A synthase 1 0.576 
 Hsd17b2 Hydroxysteroid (17-β) dehydrogenase 2 0.656 
 Ephx2 Epoxide hydrolase 2, cytoplasmic 0.664 
Inflammation and stress response 
 Cxcl14 Chemokine (c-x-c motif) ligand 14 0.610 
 Cfh Complement component factor h 1.680 
 Cxcl1 Chemokine (c-x-c motif) ligand 1 2.886 
 Ptger3 Prostaglandin e receptor 3 (subtype ep3) 0.578 
 Tollip Toll interacting protein 0.631 
 Gab1 GRB2-associated binding protein 1 1.605 
 Gadd45g Growth arrest and DNA-damage-inducible 45 γ 2.963 
 Nfe2l2 Nuclear factor, erythroid derived 2, like 2 1.693 
 Cirbp Cold inducible RNA binding protein 1.562 
 Hsph1 Heat shock 105 kd/110 kd protein 1 0.649 
Differentially expressed genes with a regulation of at least 1.5 between HFD and SC rats are represented. The fold change represents the relative 




Figure 2: Real-time RT-PCR detection of lipid metabolism–related genes. 
 
The gene expression is the relative average ΔCT as normalized to the corresponding Gapdh; each gene in the SC group was set as 1. *P < .05. 
 
 
Metabolomic profile of liver tissue extracts 
With GC/MS strategy, we identified that 5 long-chain fatty acids and 5 amino acids have 
significant differential contents in rat liver extracts (Table 3). In HFD rats, the liver had much 
higher contents of tetradecanoic acid (14:0), hexadecanoic acid (16:0), and oleic acid (18:1), but 
lower contents of polyunsaturated fatty acids, arachidonic acid (AA) (20:4), and 
eicosapentaenoic acid (EPA) (20:5). The liver contents of glucogenic amino acids including 
glycine, alanine, proline, glutamine acid, and aspartate acid were much lower in HFD rats 
compared with the SC rats. 
 
Table 3: Differential metabolites in liver between HFD and SC rats 
Metabolites RT/min Fold change (HFD/SC) 
Fatty acids   
Tetradecanoic acid 17.34 3.6 
Hexadecanoic acid 22.11 4.5 
Oleic acid 25.88 2.8 
AA 28.99 0.4 
EPA 32.71 0.3 
Amino acids   
Glycine 7.6 0.6 
Alanine 7.49 0.7 
Aspartic acid 14.08 0.4 
Glutamic acid 16.78 0.5 
Proline 24.06 0.6 
Differential metabolites between HFD (n = 20) rats and SC (n = 10) rats were identified with O-PLS-DA on SIMCA-P software. RT/min 
indicates retention time (minutes) on gas chromatograph. Fold change HFD/SC represents the HFD/SC ratio of the relative concentrations of 
differential metabolites between HFD and SC groups. 
 
DISCUSSION 
Nonalcoholic fatty liver disease is a common disease characterized by excessive triglyceride 
accumulation in the liver. Given the complexity of the pathogenesis of NAFLD, our study 
adopted a strategy of combined analysis of transcriptomic and metabolomic profiling for 
investigating NAFLD. After 16 weeks of HFD feeding, the plasma levels of lipids, glucose, and 
insulin were significantly increased. Furthermore, comprehensive variations were observed in the 
liver of rats subjected to long-term HFD feeding, including genes involved in cellular lipid 
metabolism, inflammation, and stress response. These observations increased our understanding 
of the pathways involved in the development of NAFLD induced by HFD. 
 
We found that genes involved in fatty acid β-oxidation were coordinately down-expressed, that 
is, Ppara, Cpt1, Ech1, and Dci. Ppara encodes a transcription factor that regulates genes 
involved in fatty acid uptake and β-oxidation [13,14]; Ppara-null mice chronically fed an HFD 
showed a massive accumulation of lipid in their livers[15]. Unsaturated long-chain fatty acids are 
endogenous ligands of Ppara with a high affinity for promoting Ppara-mediated fatty acid β-
oxidation in the liver [16]. As a result, the decrease of polyunsaturated long-chain fatty acids 
such as AA and EPA, as well as the down-expression of Ppara and its target genes such as Cpt1 
(the rate-limiting enzyme in fatty acid β-oxidation [17]), suggested the decreased β-oxidation of 
fatty acids in HFD rats. The higher concentrations of long-chain fatty acids such as tetradecanoic 
acid (14:0), hexadecanoic acid (16:0), and oleic acid (18:1) in the liver could result from excess 
fat intake and/or decreased fatty acid β-oxidation in HFD rats. Collectively, the gene expression 
and metabolite profiles consistently suggested the decreased β-oxidation of fatty acid after long-
term HFD feeding. 
 
Arachidonic acid and EPA are downstream products of essential fatty acids including linoleic 
acid and α-linolenic acid [18]. As HFD rats took in the same amount of food as SC rats, the 
lesser proportion of polyunsaturated fatty acid in HFD might result in the decrease of AA and 
EPA in HFD rat livers. Furthermore, the repressed expression of Fads1, which participates in the 
synthesis of polyunsaturated fatty acids, could contribute to the decrease of AA and EPA. 
Stearoyl–coenzyme A desaturase 1, a δ-9 fatty acid desaturase, converts saturated fatty acids into 
monounsaturated fatty acids. It has been suggested that its activity influences fatty acid 
partitioning by promoting fatty acid synthesis but decreasing β-oxidation. The expression Scd1 
was shown to be induced by saturated fatty acids [19-21]. Thus, increased saturated fatty acids 
like tetradecanoic acid (14:0) and hexadecanoic acid (16:0) may have contributed to the 
overexpression of Scd1, which subsequently induced the increase of oleic acid (18:1) in rat 
livers. In addition, the increased expression of Scd1 could have contributed to the elevated 
plasma insulin and glucose levels in HFD rats, which have been shown to be related to the onset 
of diet-induced hepatic insulin resistance [22,23]. Srebp1 controls cholesterol homeostasis by 
stimulating the transcription of sterol-regulated genes [24], thus regulating lipid biosynthesis 
[25]. Insig1 binds to the sterol-sensing domains of SREBP cleavage-activating protein and is 
essential for the retention of the protein in endoplasmic reticulum [26]. Taken together, the 
overexpression of Srebf1 and down-expression of Insig1 may promote the lipogenesis in rat 
liver. 
 
In our experiment, we found that glucogenic amino acids decreased whereas lipids accumulated 
in HFD rat liver tissues, which symphonized with the elevation of serum lipids, glucose, and 
insulin, although no significant expression regulations of the glyconeogenesis-participating 
enzymes were found (data not shown). This was consistent with the hypoaminoacidemic effect 
involved in glucogenic amino acids by lipid over administration [27] and the elevation of plasma 
glucogenic amino acids caused by acute caloric restriction [28]. As PPARα deficiency could 
develop mice obesity but protect mice from insulin resistance caused by being fed an HFD [29], 
and PPARα agonist could increase plasma levels of amino acids [30], the repressed expression of 
PPARα placed a protective role for the lipid and glucose metabolism regulation network. 
 
Although no significantly elevated levels of liver damage marker enzymes alkaline phosphatase, 
aspartate transaminase, and alanine transaminase were detected (data not shown), inflammation 
is still thought to play an important role in the progression from hepatic steatosis to nonalcoholic 
steatohepatitis [31]. In this study, we observed a number of differentially expressed genes 
involved in inflammation and stress response in HFD rat livers, such as the up-regulated 
expression of Cxcl1, which is a neutrophil chemoattractant that plays a role in acute phase 
inflammatory response [32,33], and Cfh, which encodes complement component factor h to 
facilitate complement-mediated cascade activation. Oxidative stress was one of the important 
factors in NAFLD development; and decreased activities of superoxide dismutase, glutathione 
peroxidase, and glutathione-S-transferase were often reported. In our study, at the gene 
expression level, no significant expression regulations were detected in the HFD rat livers 
(Supplementary material Figure S1). 
 
This study measured the variations in the metabolomic and transcriptomic profiles of HFD-fed 
rats relative to the control group fed with standard rat chow. Such variations in liver metabolome 
and transcriptome were caused by the dietary content of 10% lard, 5% egg yolk powder, and 2% 
cholesterol (whereas the other 83% remained the same as standard rat chow) and therefore may 
not readily mimic the biochemical variations of NAFLD phenotype. However, these variations 
assessed by the 2 profiling approaches are correlated with each other and consistent with the 
relevant studies of HFD-induced fatty liver [34,35]. The contribution of “exogenous” metabolites 
from dietary amino and fatty acids in our metabolic data was eliminated, as our analyses only 
focused on the liver tissues instead of biofluids such as blood and urine. 
 
In conclusion, we demonstrated through the integrated study of transcriptome and metabolome 
profiles that long-term HFD feeding results in multidimensional alterations in rat livers. 
Especially fatty acid metabolism, such as inhibited β-oxidation and enhanced lipogenesis (Fig. 
3), and inflammatory and stress responses–related genes are regulated. Further investigations of 
these differentially expressed genes and metabolic pathways are of particular significance in the 
mechanistic study of HFD-induced NAFLD. 
 
 
Figure 3: Ideogram illustration of integrated gene expressions and metabolites in HFD rat liver. 
 
The bioprocess is represented as dashed rectangles; the metabolites, as names; and the genes, as symbols. The arrows indicate the content or 
expression regulations, and the “+” and “−” indicate the positive or negative regulatory functions. 
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